Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus Combined with LE/T for Refractory Vernal Keratoconjunctivitis
NCT03464435Phase 4Completed
- Sponsor
- Zhongshan Ophthalmic Center
- Start
- Nov 2016
- Primary completion
- Nov 2017
- Modality
- RNA-Targeting Small Molecules
01
Overview
A Phase 4 trial of tacrolimus in Vernal Keratoconjunctivitis (VKC), sponsored by Zhongshan Ophthalmic Center. Started Nov 2016; status: completed.
02
Drugs
tacrolimus
03
Conditions
Vernal Keratoconjunctivitis (VKC)
Beyond the preview
Go deeper on NCT03464435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03464435.